DK2861236T3 - Farmaceutisk sammensætning, der indeholder phosphatbindende polymer - Google Patents

Farmaceutisk sammensætning, der indeholder phosphatbindende polymer Download PDF

Info

Publication number
DK2861236T3
DK2861236T3 DK12732788.0T DK12732788T DK2861236T3 DK 2861236 T3 DK2861236 T3 DK 2861236T3 DK 12732788 T DK12732788 T DK 12732788T DK 2861236 T3 DK2861236 T3 DK 2861236T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
composition containing
containing phosphate
bonding polymer
phosphate bonding
Prior art date
Application number
DK12732788.0T
Other languages
English (en)
Inventor
Evangelos Karavas
Efthimios Koutris
Vasiliki Samara
Amalia Diakidou
Georgia Papanikolaou
Panagiotis Mparmpalexis
Original Assignee
Pharmathen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmathen Sa filed Critical Pharmathen Sa
Application granted granted Critical
Publication of DK2861236T3 publication Critical patent/DK2861236T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
DK12732788.0T 2012-06-15 2012-06-15 Farmaceutisk sammensætning, der indeholder phosphatbindende polymer DK2861236T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2012/002547 WO2013185789A1 (en) 2012-06-15 2012-06-15 Pharmaceutical composition containing phosphate binding polymer

Publications (1)

Publication Number Publication Date
DK2861236T3 true DK2861236T3 (da) 2019-10-14

Family

ID=46465179

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12732788.0T DK2861236T3 (da) 2012-06-15 2012-06-15 Farmaceutisk sammensætning, der indeholder phosphatbindende polymer

Country Status (16)

Country Link
US (1) US9849147B2 (da)
EP (1) EP2861236B1 (da)
AU (1) AU2012382602B2 (da)
CA (1) CA2876739C (da)
CY (1) CY1122094T1 (da)
DK (1) DK2861236T3 (da)
ES (1) ES2748578T3 (da)
HR (1) HRP20191669T1 (da)
HU (1) HUE045603T2 (da)
LT (1) LT2861236T (da)
PL (1) PL2861236T3 (da)
PT (1) PT2861236T (da)
RS (1) RS59365B1 (da)
SI (1) SI2861236T1 (da)
WO (1) WO2013185789A1 (da)
ZA (1) ZA201500452B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10245284B2 (en) * 2015-08-19 2019-04-02 Alpex Pharma S.A. Granular composition for oral administration

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629013A (en) 1991-04-04 1997-05-13 The Procter & Gamble Company Chewable calcium carbonate antacid tablet compositions
EP0713389A4 (en) 1993-08-13 1997-05-21 Bayer Ag HYDROLYSED GELATINE AS A TASTE IMPROVER IN A CHEWABLE TABLET
US6270790B1 (en) 1998-08-18 2001-08-07 Mxneil-Ppc, Inc. Soft, convex shaped chewable tablets having reduced friability
JP2005526104A (ja) 2002-04-04 2005-09-02 ファイザー・プロダクツ・インク 味の良い咀嚼可能な錠剤
WO2006016695A1 (ja) * 2004-08-10 2006-02-16 Ono Pharmaceutical Co., Ltd. Ep4アゴニストを含有してなる高カリウム血症の予防および/または治療剤
US7749536B2 (en) 2006-02-14 2010-07-06 Teva Pharmaceutical Industries Ltd. Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture
WO2008062437A2 (en) 2006-09-01 2008-05-29 Usv Limited Process for the preparation of sevelamer hydrochloride and formulation thereof
WO2009034540A1 (en) 2007-09-11 2009-03-19 Ranbaxy Laboratories Limited Pharmaceutical composition of sevelamer
US8133506B2 (en) * 2008-03-12 2012-03-13 Aptalis Pharmatech, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
SG10201407947WA (en) * 2009-11-30 2015-01-29 Aptalis Pharmatech Inc Compressible-coated pharmaceutical compositions and tablets and methods of manufacture
WO2011135591A2 (en) * 2010-04-29 2011-11-03 Shasun Pharmaceuticals Limited Novel tablet composition of polyallylamine polymers

Also Published As

Publication number Publication date
PL2861236T3 (pl) 2020-03-31
CY1122094T1 (el) 2020-11-25
HRP20191669T1 (hr) 2019-12-13
LT2861236T (lt) 2019-09-25
HUE045603T2 (hu) 2020-01-28
WO2013185789A1 (en) 2013-12-19
RS59365B1 (sr) 2019-11-29
SI2861236T1 (sl) 2019-10-30
ZA201500452B (en) 2016-10-26
AU2012382602A1 (en) 2015-01-22
CA2876739A1 (en) 2013-12-19
US9849147B2 (en) 2017-12-26
CA2876739C (en) 2019-02-26
EP2861236B1 (en) 2019-07-17
PT2861236T (pt) 2019-10-28
ES2748578T3 (es) 2020-03-17
AU2012382602B2 (en) 2016-02-11
US20150182555A1 (en) 2015-07-02
EP2861236A1 (en) 2015-04-22

Similar Documents

Publication Publication Date Title
BR112015002738A2 (pt) composto , e , composição farmacêutica
DK3181128T3 (da) Farmaceutisk nilotinib-sammensætning
FR2997014B1 (fr) Composition sterile dermo-injectable
DK2939692T3 (da) Nasal influenzavaccinesammensætning
BR112015004936A2 (pt) composição farmacêutica revestida contendo regorafenib
BR112014032798A2 (pt) composição
DK3043778T3 (da) Farmaceutiske sammensætninger, der indeholder refametinib
BR112015003259A2 (pt) composto, composição farmacêutica, e, composição de vacina.
DK2897594T3 (da) Farmaceutisk sammensætning
DK2815752T3 (da) Oral farmaceutisk sammensætning
BR112015010797A2 (pt) compostos aniônicos substituídos, e, composição farmacêutica
CL2014003283A1 (es) Formulación farmacéutica.
IL266415A (en) Innovative pharmaceutical composition
BR112014001429A2 (pt) composição de resina
BR112015003116A2 (pt) preparação farmacêutica sólida contendo levotiroxina
DK2740750T3 (da) Polyurethanbaserede klæbemidler
BR112014032712A2 (pt) composição
ES1078291Y (es) Tapón dosificador Bi-flujo
BR112014028443A2 (pt) composição estéril.
BR112015002646A2 (pt) composto e composição farmacêutica
SMT201600419B (it) Composizione farmaceutica contenente fosfolipidi
BR112014032501A2 (pt) composto, e, composição farmacêutica.
DK2851075T3 (da) Præparat, der indeholder 6,7-umættet -7-carbamoylmorphinanderivat
DK2900721T3 (da) Urethanalkyd, der omfatter stærke syregrupper
DK2861236T3 (da) Farmaceutisk sammensætning, der indeholder phosphatbindende polymer